| Literature DB >> 27213083 |
Shubhankar Mishra1, Ramya Ramanathan1, Sunil Kumar Agarwalla1.
Abstract
Background. In India, dengue epidemics are becoming more frequent (WHO, 2008). The majority of dengue viral infections are self-limiting, but complications may cause high morbidity and mortality. Objectives. To assess the clinical profile of the dengue infection in children less than 14 years of age and to evaluate the outcomes of dengue fever from September 2013 to August 2015 at the Pediatric Department of Maharaja Krishna Chandra Gajapati Medical College, the largest tertiary care hospital of southern Odisha. Results. A total of 97 cases were classified into 84 (86.59%) nonsevere and 13 (13.40%) severe dengue cases. The most common age of presentation was above 11 yrs. The mean age of admission was 8.7 yrs. The most common presenting symptom was fever seen in 100% and hepatomegaly (43.8%), the most common physical finding. Gastrointestinal bleeding was markedly seen in severe dengue (76.9%). Elevation in aspartate transaminase (SGOT) was found in 47.42% and thrombocytopenia in 27.5%. The correlation between hepatomegaly and elevated SGOT was significant (P value 0.0346). Case fatality rate (CFR) was 1.03%. The mean duration of hospitalisation was 3.8 days. Conclusion. In children, if symptoms like fever, pain, rashes, and vomiting are associated with hepatomegaly and elevated SGOT in context of low TPC, a strong possibility of dengue fever is present, especially in an epidemic setting. Early suspicion and effective management can reduce the severity.Entities:
Year: 2016 PMID: 27213083 PMCID: PMC4860230 DOI: 10.1155/2016/6391594
Source DB: PubMed Journal: Scientifica (Cairo) ISSN: 2090-908X
Epidemiology.
| Parameter | Variables | Numbers | % | Nonsevere dengue | Severe dengue | Stats |
|---|---|---|---|---|---|---|
| Age | <3 yrs | 15 | 15.4% | 15 | 0 | Mean age |
| 4–7 yrs | 22 | 22.6% | 21 | 1 | ||
| 8–11 yrs | 27 | 27.8% | 24 | 3 | ||
| >11 yrs | 33 | 34% | 24 | 9 | ||
|
| ||||||
| Sex | Male | 75 | 77.3% | 66 | 9 | |
| Female | 22 | 22.7% | 18 | 4 | ||
|
| ||||||
| Duration of hospitalisation | 0–3 days | 28 | 28.8% | 27 | 1 | Mean duration |
| 3–6 days | 62 | 63.9% | 57 | 5 | ||
| >6 days | 7 | 7.2% | 0 | 7 | ||
|
| ||||||
| Day of admission | 0–3 days | 41 | 42.2% | 38 | 3 | Mean day |
| 3–6 days | 51 | 52.5% | 43 | 8 | ||
| >6 days | 5 | 5.1% | 3 | 2 | ||
|
| ||||||
| Classification | Undifferentiated fever | 31 | 31.9% | |||
| DF (with and without warning signs) | 53 | 54.6% | ||||
| Severe dengue fever (DHF) | 13 | 13.4% | ||||
Investigation.
| Investigations | Variations | Nonsevere dengue ( | Severe dengue ( | Total ( |
|
|---|---|---|---|---|---|
| TLC | Leukopenia (<4000 cells/mm3) | 22 (26.19%) | 3 (23.07%) | 25 (25.77%) | |
| Leukocytosis (>11000 cells/mm3) | 13 (15.47%) | 2 (15.38%) | 15 (15.46%) | ||
| Normal TLC (4000–11000/mm3) | 49 (58.33%) | 8 (61.53%) | 57 (58.7%) | ||
|
| |||||
| Liver enzymes | Rise in SGPT (IU/L) | ||||
| Total | 25 (29.76%) | 5 (38.46%) | 30 (30.92%) | 0.5326 | |
| 50–200 U | 23 | 1 | |||
| 200–1000 U | 2 | 1 | |||
| >1000 U | 0 | 3 | |||
| Rise in SGOT (IU/L) | |||||
| Total | 36 (42.85%) | 10 (76.92%) | 46 (47.42%) | 0.0346 | |
| 50–200 U | 31 | 1 | |||
| 200–1000 U | 5 | 4 | |||
| >1000 U | 0 | 5 | |||
|
| |||||
| TPC | >100001 | 66 (78.57%) | 4 (30.76%) | 70 (72.16%) | |
| 100000–50001 | 12 (14.28%) | 4 (30.76%) | 16 (16.49%) | ||
| <50000 | 6 (7.14%) | 5 (38.46%) | 11 (11.34%) | ||
|
| |||||
| Haematocrit | >36.3% | 27 (32.14%) | 6 (46.15%) | 33 (34.02%) | |
| <36.3% | 57 (67.85%) | 7 (53.84%) | 64 (65.97%) | ||
|
| |||||
| Chest X-ray | Pleural effusion | 17 (20.23%) | 8 (61.53%) | 25 (25.77%) | 0.0037 |
| Right sided effusion | 12 (14.28%) | 3 (23.07%) | 15 (15.46%) | 0.4179 | |
| Left sided effusion | 4 (4.76%) | 0 | 4 (4.12%) | ||
| Right + left effusion | 1 (1.19%) | 5 (38.46%) | 6 (6.18%) | 0.0001 | |
|
| |||||
| USG of abdomen | Hepatomegaly | 41 (48.80%) | 10 (76.92%) | 51 (52.57%) | |
| Ascites | 19 (22.61%) | 6 (46.15%) | 25 (25.77%) | ||
| Gall bladder wall edema | 0 | 2 (15.38%) | 2 (2.06%) | ||
|
| |||||
| Dengue serology | NS1 | 43 (51.19%) | 3 (23.07%) | 46 (47.42%) | |
| IgM | 30 (35.71%) | 2 (15.38%) | 32 (32.98%) | ||
| IgG | 3 (3.57%) | 0 | 3 (3.09%) | ||
| IgM & IgG | 5 (5.95%) | 6 (46.15%) | 11 (11.30%) | ||
| NS1 & IgM | 3 (3.57%) | 2 (15.38%) | 5 (5.14%) | ||
Significant P value.
Hepatic manifestations.
| Bleeding manifestations |
| |||
|---|---|---|---|---|
| Present | Absent | Total | ||
| Thrombocytopenia | 0.3314 | |||
| Present | 11 | 16 | 27 | |
| Absent | 20 | 50 | 70 | |
| Total | 31 | 66 | 97 | |
| Hepatomegaly | 0.2784 | |||
| Present | 17 | 26 | 43 | |
| Absent | 15 | 39 | 54 | |
| Total | 32 | 65 | 97 | |
| Raised SGOT | 0.2808 | |||
| Present | 18 | 28 | 46 | |
| Absent | 14 | 37 | 51 | |
| Total | 32 | 65 | 97 | |
Management.
| Management | Nonsevere dengue ( | Severe dengue ( | Total ( |
|---|---|---|---|
| Antipyretics | 84 | 13 | 97 |
| Intravenous fluids | 17 (20.23%) | 10 (76.92%) | 27 (27.83%) |
| Platelet transfusion | 0 | 4 (30.76%) | 4 (4.12%) |
| Whole fresh blood transfusion | 0 | 4 (30.76%) | 4 (4.12%) |
| Dopamine | 0 | 4 (30.76%) | 4 (4.12%) |
| Adrenaline | 0 | 1 (7.69%) | 1 (1.03%) |